Daniel Judge, MD, on Making Genetic Testing, Insights More Mainstream


MUSC recently launched In Your DNA SC, a 4-year study to collect and glean insights from genetic testing in the general population.

The time is now for genetics to become much more clinically available and informative and hopefully something that will drive better therapies.

As recent as 2 decades ago, the thought of applying genetic insights to clinical care was merely a pipe dream. Today, genetic testing is available and more accessible, and translational research continues to show the value of these insights into both personalized approaches to care as well as the development of new, targeted therapeutics.

Yet, we still have so much to learn, and that is the motivation behind "In Our DNA SC," a community research project recently launched by the Medical University of South Carolina (MUSC) and Helix. The state-wide initiative will offer no-cost genetic testing for 100,000 individuals to assess for actionable information related to certain types of cancer and cardiovascular disease. Not only will patients be able to review these key findings with their providers, but participants will also be contributing to one of the largest clinical-genomic datasets that will be used for future research.

To learn more about the initiative and the increasing role of genetics in everyday clinical care, CGTLive spoke with Daniel Judge, MD, professor of medicine in cardiology, MUSC.

Related Videos
Zheng-Yi Chen, DPhil, on International Collaboration on Clinical Trials
Janice Chen, PhD, the cofounder and chief technology officer of Mammoth Biosciences
Sekar Kethiresan, MD, on Following up VERVE-101 With Next-Generation Editing Therapies
Maria Escolar, MD, the chief medical officer of Forge Biologics
Leigh Ramos-Platt, MD, on Allowing Access and Ensuring Preparation for Gene Therapies
John Murphy, PhD, the chief scientific officer of Arbor Biotechnologies
Erika Fullwood Augustine, MD, MS, the associate chief science officer of the Kennedy Krieger Institute
Maria Escolar, MD, the chief medical officer of Forge Biologics
Casey Maguire, PhD, associate professor of neurology and associate investigator of neurology, Harvard Medical School
Faraz Ali, MBA, the chief executive officer of Tenaya Therapeutics
© 2024 MJH Life Sciences

All rights reserved.